Personal information

Websites & social links

Google Scholar

Other IDs

Scopus Author ID: 56247555300

Keywords

Hepatology

Countries

Egypt

Activities

Collapse all

Employment (3)

Portsaid University Faculty of Medicine: Portsaid, EG

2017-01 to present | Assistant Lecturer (Tropical Medicine)
Employment
Source: Self-asserted source
Reham soliman

Egyptian Liver research Institute and Hospital : Mansoura, EG

2008-05 to present (Gastroenterology and Hepatology)
Employment
Source: Self-asserted source
Reham soliman

Mansoura University Faculty of Medicine: Mansoura, EG

2003-03 to 2008-02 (Tropical Medicine)
Employment
Source: Self-asserted source
Reham soliman

Education and qualifications (2)

Mansoura University Faculty of Medicine: Mansoura, EG

2002 to present | MBBCH
Education
Source: Self-asserted source
Reham soliman

Mansoura University Faculty of Medicine: Mansoura, EG

2008-05 | Master Degree (Tropical Medicine)
Education
Source: Self-asserted source
Reham soliman

Works (25)

Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience

Hepatology International
2018 | Journal article
DOI: 10.1007/s12072-018-9861-2
EID:

2-s2.0-85045427370
Contributors: Shiha, G.; Soliman, R.; ElBasiony, M.; Hassan, A.A.; Mikhail, N.N.H.
Source: Self-asserted source
Reham soliman via Scopus - Elsevier

Change in hepatic profile in hepatitis C virus genotype 4 patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: a subanalysis of the AGATE‐II study

Journal of Medical Virology
2018-06-13 | Journal article
Source: Self-asserted source
Reham soliman

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt

GUT
2018-04-17 | Journal article
Source: Self-asserted source
Reham soliman

A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C

Hepatology International
2017 | Journal article
DOI: 10.1007/s12072-017-9796-z
EID:

2-s2.0-85019050468
Contributors: Shiha, G.; Seif, S.; Eldesoky, A.; Elbasiony, M.; Soliman, R.; Metwally, A.; Zalata, K.; Mikhail, N.
Source: Self-asserted source
Reham soliman via Scopus - Elsevier

A Novel Single Daily Fixed Dose Combination of Sofosbuvir400 mg + Ribavirin1000mg + EGCG400 mg is Superior to the Standard of Care as an Anti-Viral and Safer Causing less Hemolysis in Patients with Chronic Hepatitis C

EASL
2017-04 | Conference abstract
Source: Self-asserted source
Reham soliman

A Novel Single Daily Fixed Dose Combination of Sofosbuvir400 mg + Ribavirin1000mg + EGCG400 mg is Superior to the Standard of Care as an Anti-Viral and Safer Causing less Hemolysis in Patients with Chronic Hepatitis C

Hepatology
2016 | Conference paper
Source: Self-asserted source
Reham soliman

Improved Hepatic Profile in Hepatitis C Virus (HCV) Genotype (GT) 4-Infected Egyptian Patients With Compensated Cirrhosis Receiving Ombitasvir/Paritaprevir/Ritonavir With Ribavirin (AGATE-II)

HEPATOLOGY
2016 | Conference paper
Source: Self-asserted source
Reham soliman

Ledipasvir/Sofosbuvir in Egyptian Patients with Chronic Genotype 4 HCV Infection

Hepatology
2016 | Conference paper
Source: Self-asserted source
Reham soliman

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial

The Lancet Gastroenterology and Hepatology
2016 | Journal article
DOI: 10.1016/S2468-1253(16)30002-4
EID:

2-s2.0-84996527481
Contributors: Waked, I.; Shiha, G.; Qaqish, R.B.; Esmat, G.; Yosry, A.; Hassany, M.; Soliman, R.; Mohey, M.A.; Allam, N.; Zayed, N. et al.
Source: Self-asserted source
Reham soliman via Scopus - Elsevier

Ombitasvir/Paritaprevir/Ritonavir with Ribavirin Achieves High Sustained Virologic Response (SVR) Rates in Egyptian Adults with Chronic HCV Genotype 4 Infection (Agate-II)

Journal of Hepatology
2016 | Conference paper
Source: Self-asserted source
Reham soliman

The C13-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study

Hepatology
2016 | Conference paper
Source: Self-asserted source
Reham soliman

Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients

Medical Journal of Viral Hepatitis
2016-11 | Journal article
Source: Self-asserted source
Reham soliman

Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience

Medical Journal of viral hepatitis
2016-11 | Journal article
Source: Self-asserted source
Reham soliman

Evaluation of Transient Elastography in Diagnosis of Esophageal Varices in Chronic Hepatitis C Patients

MJECLF
2015 | Journal article
Source: Self-asserted source
Reham soliman

Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4

Journal of Hepatology
2015 | Journal article
DOI: https://doi.org/10.1016/j.jhep.2015.04.023
Source: Self-asserted source
Reham soliman
grade
Preferred source (of 2)‎

Sofosbuvir plus Ribavirin in the Treatment of Egyptian Patients with Chronic Genotype 4 HCV Infection

Hepatology
2015 | Conference paper
Source: Self-asserted source
Reham soliman

Sofosbuvir plus ribavirin in the treatment of Egyptian patients with chronic genotype 4 HCV infection

HEPATOLOGY
2014 | Conference paper
Source: Self-asserted source
Reham soliman

The Cc allele at rs12979860 Il28b is associated with higher hepatic fibrosis in Hcv patients with genotype 4

Hepatology
2014 | Journal article
Source: Self-asserted source
Reham soliman

The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study

Medical Journal of Viral Hepatitis
Journal article
Source: Self-asserted source
Reham soliman

A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C

Medical Journal of Viral Hepatitis
Journal article
Source: Self-asserted source
Reham soliman

An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project

Lancet Gastroenterology and Hepatology
Journal article
Source: Self-asserted source
Reham soliman

Interferon-ë rs12979860CC genotype predicts sustained virological response to therapy in patients with chronic hepatitis C Genotype 4 but enhances hepatic fibrosis

Medical Journal of Viral Hepatitis
Journal article
Source: Self-asserted source
Reham soliman

The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study

Medical Journal of Viral Hepatitis
Journal article
Source: Self-asserted source
Reham soliman

Transient elastography (FibroScan) is not useful in the diagnosis of schistosomal hepatic fibrosis

Journal article
Source: Self-asserted source
Reham soliman

↓ Full text Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience

Hepatology International
Journal article
Source: Self-asserted source
Reham soliman
How many people are using ORCID?